index - Myopathies inflammatoires & thérapies innovantes ciblées

Dernières publications

Chiffres clés

123 Publications avec texte intégral

Open Access

53 %

Mots clés

Antisynthétase Acute Kidney Injury/epidemiology/etiology Myositis and muscle disease Anti-interleukin-6 Abnormal movement Data integration Anémie hémolytique Deep immune profiling Immunotherapy IMNM Adeno-associated virus Cancer Biomarqueurs Myopathy Anti-agalsidase antibodies IBM DM B-lymphocyte Systems biology Arthritis Autoantibodies Mass cytometry Outcome measures Male Machine learning Immune checkpoint inhibitors Myocarditis Inclusion body myositis Antibodies Anti‐mitochondrial antibodies Myositis COVID-19 Antibody responses Assisted communication devices Prognosis Inflammation Gene therapy Anti-synthetase syndrome Biomarkers Anticorps anti-agalsidase Amyotrophy Auto-antibodies Autoimmunity Anti-MDA5 autoantibodies Middle Aged Adeno-associated virus vector Acid-alpha-glucosidase Idiopathic inflammatory myopathies AAV Aldosterone Biopsy Pharmacology Bioelectrical impedance analysis Amyotrophic lateral sclerosis Autoimmune diseases Dependovirus/genetics/immunology Adjudication Analyses multidimensionnelles Inborn errors of metabolism Active Adverse drug reactions Cytokines Cardio-oncology Interstitial lung disease Agalsidase Dermatomyositis Muscle Interferon Biomarker Female Adeno-associated vector Multidisciplinarity Antisynthetase syndrome B cell homeostasis Lysosomal storage diseases Adolescence Polymyositis Adult AAV vector Antisynthetase Anti-IgE IgG Anti-drug antibodies Antiphospholipid syndrome Fabry disease Autoantibody Inflammatory myopathy AAV vectors AAV humoral immunity Anti-Mi2 Auto-immunité Humans AAV antibody Skeletal muscle Auto‐antibodies Anticorps spécifique des myosites Sphingosine-1-phosphate Aged Case reports Aldostérone Animals